Author Affiliation: Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Ill.
It has been more than 4 years since Dalen and Bone1
called for either a moratorium on the use of pulmonary artery catheters (PACs)
for the management of critically ill patients or randomized clinical trials
to demonstrate their benefit. Their recommendation was in response to a retrospective
observational analysis by Connors et al2 that
reported increased mortality and cost in diverse patient groups monitored
with the PAC.
Hall JB. Use of the Pulmonary Artery Catheter in Critically Ill PatientsWas Invention the Mother of Necessity?. JAMA. 2000;283(19):2577-2578. doi:10.1001/jama.283.19.2577